Speaker illustration

Ms Karen Pieper

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)

Karen Pieper is currently the Director of the Statistical Research Scientists at the Duke Clinical Research Institute (DCRI). She has been working as a statistician in the field of cardiovascular research for over 30 years. She has experience in both clinical trials and observational research. Some of her achievements include; membership on multiple committees for the American Statistical Association, membership as a voting member of multiple data and safety monitoring committees, and past Director of the Center for Predictive Medicine at the Duke Clinical Research Institute (DCRI). Karen has given talks around the world on statistical methods. She has developed educational series for non-statisticians and was the first recipient of the DCRI fellows' Best Teaching and Support Award. This award has been since named the Karen Pieper Fellowship Teaching or Support Award.

Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention - General

Thumbnail

Can we avoid randomized clinical trials for new CV drugs? .

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session: Current controversies in clinical trial design

Thumbnail

Discussion - Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry.

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry

Thumbnail

This platform is supported by

logo Novo Nordisk